Clinical Trials Browser

Phase 1/2 × Myelodysplastic Syndromes × Oxaliplatin × Clear all

NCT00480987 2012-08-07

Oxaliplatin, Fludarabine, and Cytarabine in Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndromes (MDS)

Phase 1/2 Terminated

27 enrolled 5 charts

MyeloidOther hematologic neoplasm

Leukemia, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute